{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:06:50Z","timestamp":1781327210976,"version":"3.54.1"},"reference-count":28,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Florida Clinical and Translational Science Institute","award":["UL1TR001427"],"award-info":[{"award-number":["UL1TR001427"]}]},{"DOI":"10.13039\/100006108","name":"NIH National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001427"],"award-info":[{"award-number":["UL1TR001427"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Background: Prevention of the vertical transmission of the hepatitis C virus (HCV) presents an obstetric challenge. There are no approved antiviral medications for the treatment or prevention of HCV for pregnant patients. Objective: We aimed to create a composite score to accurately identify a population of pregnant patients with HCV who have high potential for vertical transmission. Study Design: In a retrospective, multicenter cohort study, we identified pregnant patients with hepatitis C with linked data to their infants who have had HCV RNA or HCV antibody testing. Demographic data, including age and race\/ethnicity, as well as clinical and laboratory data, including tobacco\/alcohol use, infections, liver function tests, the HCV RNA titer, HCV antibody, HCV genotype, absolute lymphocyte count, and platelet count, were collected. Data were analyzed using logistic regression and receiver operating characteristics (ROCs) and internally validated using the forward selection bootstrap method. Results: We identified 157 pregnant patients and 163 corresponding infants. The median maternal delivery age was 29 (IQR: 25\u201333) years, and the majority (141, or 89.8%) were White. A high HCV RNA titer, high absolute lymphocyte count, and high platelet count were associated with vertical transmission. A high HCV RNA titer had an AUROC of 0.815 with sensitivity, specificity, a positive predictive value, and a negative predictive value of 100.0%, 59.1%, 17.6%, and 100.0%, respectively. A composite score combining the three risk factors had an AUROC of 0.902 (95% CI = 0.840\u20130.964) but with a risk of overfitting. Conclusions: An HCV RNA titer alone or a composite score combining the risk factors for HCV vertical transmission can potentially identify a population of pregnant patients where the rate of vertical transmission is high, allowing for potential interventions during antepartum care.<\/jats:p>","DOI":"10.3390\/pathogens13010045","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T03:18:07Z","timestamp":1704251887000},"page":"45","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Composite Score for Predicting Vertical Transmission of Hepatitis C: A Multicenter Study"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7555-453X","authenticated-orcid":false,"given":"Paul","family":"Wasuwanich","sequence":"first","affiliation":[{"name":"University of Florida College of Medicine, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"So","sequence":"additional","affiliation":[{"name":"University of Florida College of Medicine, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8538-5063","authenticated-orcid":false,"given":"Brett","family":"Presnell","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of Florida, Gainesville, FL 32611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7288-5459","authenticated-orcid":false,"given":"Wikrom","family":"Karnsakul","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2063-7765","authenticated-orcid":false,"given":"Robert S.","family":"Egerman","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, University of Florida College of Medicine, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony S.","family":"Wen","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, University of Florida College of Medicine, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2017). Global Hepatitis Report 2017, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013\u20132016","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2018","journal-title":"Am. J. Public Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.amepre.2018.05.029","article-title":"Hepatitis C Virus in Women of Childbearing Age, Pregnant Women, and Children","volume":"55","author":"Schillie","year":"2018","journal-title":"Am. J. Prev. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/AOG.0000000000003644","article-title":"Reported Prevalence of Maternal Hepatitis C Virus Infection in the United States","volume":"135","author":"Rossi","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpeds.2006.11.037","article-title":"Clinical Spectrum and Histopathologic Features of Chronic Hepatitis C Infection in Children","volume":"150","author":"Mohan","year":"2007","journal-title":"J. Pediatr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1572-0241.2003.07293.x","article-title":"Fibrosis in chronic hepatitis C acquired in infancy: Is it only a matter of time?","volume":"98","author":"Guido","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: Systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/512815","article-title":"Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: A meta-analysis","volume":"44","author":"Polis","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/QAD.0b013e3282703810","article-title":"HCV\/HIV co-infection, HCV viral load and mode of delivery: Risk factors for mother-to-child transmission of hepatitis C virus?","volume":"21","author":"Giordanengo","year":"2007","journal-title":"AIDS"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/0003-4819-158-2-201301150-00575","article-title":"Reducing risk for mother-to-infant transmission of hepatitis C virus: A systematic review for the U.S. preventive services task force","volume":"158","author":"Cottrell","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1086\/497701","article-title":"Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy","volume":"192","author":"Mast","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(00)02681-7","article-title":"Mother-to-child transmission of hepatitis C virus: Evidence for preventable peripartum transmission","volume":"356","author":"Gibb","year":"2000","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00404-010-1588-9","article-title":"Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+\/HIV-mothers: A meta-analysis","volume":"283","author":"Tabatabaei","year":"2011","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_15","first-page":"10","article-title":"Vertical Transmission of Hepatitis C Virus: Variable Transmission Bottleneck and Evidence of Midgestation In Utero Infection","volume":"91","author":"Larouche","year":"2017","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"F156","DOI":"10.1136\/adc.2004.059436","article-title":"When does mother to child transmission of hepatitis C virus occur?","volume":"90","author":"Mok","year":"2005","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2666-5247(20)30062-8","article-title":"Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: A phase 1 pharmacokinetic study","volume":"1","author":"Chappell","year":"2020","journal-title":"Lancet Microbe"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"230529","DOI":"10.1136\/bcr-2019-230529","article-title":"Successful sofosbuvir lead-in monotherapy for the treatment of hepatitis C virus (HCV) infection in a pregnant woman living with HIV","volume":"12","author":"Mandimika","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1590\/S0036-46652014000200008","article-title":"Risk factors of HIV-1 vertical transmission (VT) and the influence ofantiretroviral therapy (ART) in pregnancy outcome","volume":"56","author":"Barral","year":"2014","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_20","first-page":"605","article-title":"Vertical transmission of hepatitis B virus: Challenges and solutions","volume":"6","author":"Gentile","year":"2014","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults-United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kimberlin, D., Barnett, E., Lynfield, R., and Sawyer, M. (2021). Red Book: 2021 Report of the Committee on Infectious Diseases, American Academy of Pediatrics.","DOI":"10.1542\/9781610025225"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejogrb.2015.09.009","article-title":"Risk factors for vertical transmission of hepatitis C virus: A single center experience with 710 HCV-infected mothers","volume":"194","author":"Perales","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1016\/j.ajog.2021.11.470","article-title":"Maternal viral load and risk of vertical transmission in patients with Hepatitis C","volume":"226","author":"Oliver","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.4049\/jimmunol.158.3.1473","article-title":"The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C","volume":"158","author":"Nelson","year":"1997","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1478-3231.2011.02556.x","article-title":"Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes","volume":"31","author":"Connell","year":"2011","journal-title":"Liver Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/MPG.0b013e318258328d","article-title":"NASPGHAN Practice guidelines: Diagnosis and management of hepatitis c infection in infants, children, and adolescents","volume":"54","author":"Mack","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/AOG.0000000000004760","article-title":"Postpartum Follow-up Care for Pregnant Persons with Opioid Use Disorder and Hepatitis C Virus Infection","volume":"139","author":"Jarlenski","year":"2022","journal-title":"Obstet. Gynecol."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/1\/45\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:38:43Z","timestamp":1760103523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/1\/45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["pathogens13010045"],"URL":"https:\/\/doi.org\/10.3390\/pathogens13010045","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]}}}